Memorial Sloan Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan Kettering.

Showing 61 - 80 of 141 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
  • Rare Blood Disorders
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of FOLFOX plus Regorafenib in Patients with Inoperable or Metastatic Esophageal and/or Stomach Cancer
[Protocol 13-080]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Nintedanib in Patients with Advanced Esophagogastric Cancer
[Protocol 14-094]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
[Protocol 13-066]
Jarnagin, William
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Actinomycin-D versus Methotrexate to Treat Low-Risk Gestational Trophoblastic Disease
[Protocol 13-108]
Jewell, Elizabeth
  • Uterine (Endometrial) Cancer
A Pilot Study of NovoTTF-100A for Recurrent Atypical or Anaplastic Meningioma
Relapsed/Refractory
[Protocol 13-067]
Kaley, Thomas
  • Brain Tumors, Primary
    • Other Trials
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118]
Kelsen, David
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy
  • Colorectal Cancer
A Phase III Study Evaluating of the Role of Axillary (Armpit) Lymph Node Removal in Patients with Breast Cancer with Positive Sentinel Lymph Nodes after Preoperative Chemotherapy
Newly Diagnosed
[Protocol 14-151]
King, Tari
  • Breast Cancer
A Study Assessing the Influence of Breast MRI Before Lumpectomy on Outcomes, Quality of Life, and Costs in Women with Breast Cancer
Newly Diagnosed
[Protocol 14-198]
King, Tari
  • Breast Cancer
  • Quality of Life
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031]
Kollmeier, Marisa
  • Bladder Cancer
A Study Assessing the Safety and Effectiveness of Ultra-Hypofractionated Radiation Therapy after Brachytherapy for Localized Intermediate-Risk Prostate Cancer
Newly Diagnosed
[Protocol 14-193]
Kollmeier, Marisa
  • Prostate Cancer
    • Localized Disease
Phase I Study of Olaparib in Combination with Chemotherapy in Patients Newly Diagnosed with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-220]
Konner, Jason
  • Ovarian Cancer
A Phase III Study of AEZS-108 versus Doxorubicin as Second-Line Therapy for Recurrent or Metastatic Endometrial Cancer
[Protocol 13-130]
Konner, Jason
  • Uterine (Endometrial) Cancer
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana
  • Breast Cancer
A Phase I/IIA Study of Carfilzomib plus High-Dose Melphalan Before Autologous Stem Cell Transplant in Patients with Multiple Myeloma
[Protocol 12-144]
Landau, Heather
  • Hematology
    • Multiple Myeloma
A Phase II Study of Capecitabine with Lapatinib or Neratinib in Patients with Metastatic HER2-Positive Breast Cancer
[Protocol 13-121]
Latif, Asma
  • Breast Cancer